Antibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN967419 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Tumor Protein P53 (TP53) (AA 14-289) antibody
- Antibody type
- Monoclonal
- Antigen
- Human p53
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- PAb 240
- Vial size
- 0.1 mg
- Concentration
- 0.5 mg/ml
- Storage
- Store undiluted at 4°C.
Submitted references p53 immunohistochemical analysis in breast cancer with four monoclonal antibodies: comparison of staining and PCR-SSCP results.
An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53.
p53 mutations are not selected for in simian virus 40 T-antigen-induced tumors from transgenic mice.
Immunohistochemical analysis of p53 expression in malignant lymphomas.
Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies.
Expression of p53 protein in infiltrating and in-situ breast carcinomas.
Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form.
Jacquemier J, Molès JP, Penault-Llorca F, Adélaide J, Torrente M, Viens P, Birnbaum D, Theillet C
British journal of cancer 1994 May;69(5):846-52
British journal of cancer 1994 May;69(5):846-52
An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53.
Vojtĕsek B, Bártek J, Midgley CA, Lane DP
Journal of immunological methods 1992 Jul 6;151(1-2):237-44
Journal of immunological methods 1992 Jul 6;151(1-2):237-44
p53 mutations are not selected for in simian virus 40 T-antigen-induced tumors from transgenic mice.
Moore M, Teresky AK, Levine AJ, Seiberg M
Journal of virology 1992 Feb;66(2):641-9
Journal of virology 1992 Feb;66(2):641-9
Immunohistochemical analysis of p53 expression in malignant lymphomas.
Said JW, Barrera R, Shintaku IP, Nakamura H, Koeffler HP
The American journal of pathology 1992 Dec;141(6):1343-8
The American journal of pathology 1992 Dec;141(6):1343-8
Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies.
Bártek J, Bártková J, Vojtĕsek B, Stasková Z, Lukás J, Rejthar A, Kovarík J, Midgley CA, Gannon JV, Lane DP
Oncogene 1991 Sep;6(9):1699-703
Oncogene 1991 Sep;6(9):1699-703
Expression of p53 protein in infiltrating and in-situ breast carcinomas.
Walker RA, Dearing SJ, Lane DP, Varley JM
The Journal of pathology 1991 Nov;165(3):203-11
The Journal of pathology 1991 Nov;165(3):203-11
Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form.
Gannon JV, Greaves R, Iggo R, Lane DP
The EMBO journal 1990 May;9(5):1595-602
The EMBO journal 1990 May;9(5):1595-602
No comments: Submit comment
No validations: Submit validation data